BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36698398)

  • 1. Canine oral squamous cell carcinoma as a spontaneous, translational model for radiation and immunology research.
    Boss MK; Harrison LG; Gold A; Karam SD; Regan DP
    Front Oncol; 2022; 12():1033704. PubMed ID: 36698398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Cytotoxic T Lymphocytes and Natural Killer Cell Distribution in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: An Immunohistochemical Study.
    John S; Joseph AP; Raghavan Pillai VB; Ramani P; P J; Ramalingam K
    Cureus; 2024 Mar; 16(3):e56323. PubMed ID: 38628992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptomics reveal the intratumoral landscape of infiltrated T-cell subpopulations in oral squamous cell carcinoma.
    Chen J; Yang J; Li H; Yang Z; Zhang X; Li X; Wang J; Zhang Y; Chen S; Song M
    Mol Oncol; 2021 Apr; 15(4):866-886. PubMed ID: 33513276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival.
    Yu Y; Tang H; Franceschi D; Mujagond P; Acharya A; Deng Y; Lethaus B; Savkovic V; Zimmerer R; Ziebolz D; Li S; Schmalz G
    Front Med (Lausanne); 2021; 8():759605. PubMed ID: 35127742
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Chen Z; Chen Q; Li S; Tu S; Chen Q; Wang A
    Ann Transl Med; 2022 Feb; 10(3):144. PubMed ID: 35284546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma.
    Yu X; Xu L; Zhou Y; Zhou X; Yang L; Zhou Y
    J Inflamm Res; 2023; 16():3799-3809. PubMed ID: 37663758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
    Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
    Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
    Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
    Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond PD-L1-Identification of Further Potential Therapeutic Targets in Oral Cancer.
    Weber M; Lutz R; Olmos M; Glajzer J; Baran C; Nobis CP; Möst T; Eckstein M; Kesting M; Ries J
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation.
    Kenison JE; Wang Z; Yang K; Snyder M; Quintana FJ; Sherr DH
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33941684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy.
    Boss MK; Watts R; Harrison LG; Hopkins S; Chow L; Trageser E; Easton C; LaRue SM; Regan D; Dewhirst MW; Dow S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICOSLG-associated immunological landscape and diagnostic value in oral squamous cell carcinoma: a prospective cohort study.
    Dong Y; Hu X; Xie S; Song Y; He Y; Jin W; Ni Y; Wang Z; Ding L
    Front Cell Dev Biol; 2023; 11():1257314. PubMed ID: 37842091
    [No Abstract]   [Full Text] [Related]  

  • 14. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.
    Foy JP; Bertolus C; Michallet MC; Deneuve S; Incitti R; Bendriss-Vermare N; Albaret MA; Ortiz-Cuaran S; Thomas E; Colombe A; Py C; Gadot N; Michot JP; Fayette J; Viari A; Van den Eynde B; Goudot P; Devouassoux-Shisheboran M; Puisieux A; Caux C; Zrounba P; Lantuejoul S; Saintigny P
    Ann Oncol; 2017 Aug; 28(8):1934-1941. PubMed ID: 28460011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased tumor-infiltrating plasmacytoid dendritic cells predicts poor prognosis in oral squamous cell carcinoma.
    Han N; Zhang Z; Liu S; Ow A; Ruan M; Yang W; Zhang C
    Arch Oral Biol; 2017 Jun; 78():129-134. PubMed ID: 28242507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
    Xiao T; Lin F; Zhou J; Tang Z
    Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of
    de Vos L; Grünwald I; Bawden EG; Dietrich J; Scheckenbach K; Wiek C; Zarbl R; Bootz F; Landsberg J; Dietrich D
    Epigenetics; 2020 Nov; 15(11):1195-1212. PubMed ID: 32281488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
    Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
    Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.